Rockbridge Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-20
Closed -$10.6K – 573
2023
Q4
$10.6K Buy
+20
New +$9.68K ﹤0.01% 394
2022
Q3
– Sell
-20
Closed -$10.9K – 545
2022
Q2
$10.9K Hold
20
– – ﹤0.01% 361
2022
Q1
$11.8K Sell
20
-175
-90% -$101K ﹤0.01% 489
2021
Q4
$130K Hold
195
– – 0.02% 220
2021
Q3
$111K Hold
195
– – 0.02% 219
2021
Q2
$98K Hold
195
– – 0.02% 230
2021
Q1
$89K Buy
195
+4
+2% +$1.91K 0.02% 225
2020
Q4
$89K Hold
191
– – 0.02% 217
2020
Q3
$84K Buy
191
+173
+961% +$71.5K 0.02% 203
2020
Q2
$7K Buy
+18
New +$6.03K ﹤0.01% 466

Other funds holding TMO

Rockbridge Investment Management's TMO Position: Q1 2024 in Review

Rockbridge Investment Management sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 20 shares — an estimated $10.6K sold.

Rockbridge Investment Management first reported a position in TMO in Q2 2020 and held it in 10 quarters. The position peaked at $130K in Q4 2021. 2,534 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

  • Rockbridge Investment Management reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
  • Rockbridge Investment Management sold 20 Thermo Fisher Scientific shares in Q1 2024, an estimated $10.6K.
  • Rockbridge Investment Management first reported a position in Thermo Fisher Scientific in Q2 2020 and held it in 10 quarters.
  • Rockbridge Investment Management's Thermo Fisher Scientific position peaked at $130K in Q4 2021.
  • 2,534 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Rockbridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.